Apellis Pharmaceuticals, Inc. earnings per share and revenue

APLS earnings per share for the last quarter are -0.46 USD whereas the estimation was -0.29 USD which accounts for -55.96% surprise. Company revenue for the same period amounts to 196.83 M USD despite the estimated figure of 200.00 M USD. Estimated earnings per share for the next quarter are -0.37 USD, and revenue is expected to reach 193.75 M USD. Also watch annual changes over time to get a bigger picture of APLS earnings per share and revenue dynamics.